Stayble Therapeutics AB (STABL) — Financial Flexibility Index
Stayble Therapeutics AB (STABL) has a Financial Flexibility Index of 3.17x as of December 2025. Free cash flow of Skr5.38 Million (operating CF Skr-1.34 Million minus capex Skr6.72 Million) represents 3% of total liabilities (Skr1.70 Million). Check STABL cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Stayble Therapeutics AB Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Stayble Therapeutics AB across 10 annual periods. See Stayble Therapeutics AB (STABL) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Stayble Therapeutics AB (2016–2025)
Year-by-year free cash flow to debt coverage for Stayble Therapeutics AB. For the full company profile including market capitalisation, see Stayble Therapeutics AB (STABL) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-6.72 Million | Skr1.70 Million | ▲ +100.0% |
| 2024 | -6.15x | Skr-14.67 Million | Skr-14.67 Million | Skr2.38 Million | ▼ -35.8% |
| 2023 | -4.53x | Skr-23.54 Million | Skr-23.54 Million | Skr5.19 Million | ▲ +29.6% |
| 2022 | -6.44x | Skr-24.89 Million | Skr-24.89 Million | Skr3.87 Million | ▼ -156.0% |
| 2021 | -2.51x | Skr-9.63 Million | Skr-9.63 Million | Skr3.83 Million | ▲ +74.3% |
| 2020 | -9.80x | Skr-23.98 Million | Skr-23.98 Million | Skr2.45 Million | ▼ -33999.6% |
| 2019 | 0.03x | Skr289.39K | Skr289.39K | Skr10.01 Million | ▲ +101.0% |
| 2018 | -2.87x | Skr-5.42 Million | Skr-5.42 Million | Skr1.89 Million | ▼ -400.9% |
| 2017 | -0.57x | Skr-694.20K | Skr-2.62 Million | Skr1.21 Million | ▼ -127.0% |
| 2016 | 2.12x | Skr2.33 Million | Skr-1.39 Million | Skr1.10 Million | — |